TP53TG5 is a p53-inducible gene localized to chromosome 20.1 that encodes a 290-amino-acid protein with no significant homology to known proteins 1. Primary Function: TP53TG5 functions as a growth suppressor downstream of p53-mediated signaling 1. The protein demonstrates growth-suppressive effects, as demonstrated by colony-formation assays in p53-deficient glioblastoma cells 1. Mechanism: The gene exhibits cell cycle-dependent regulation of expression and shows dynamic intracellular localization patterns that vary throughout the cell cycle, suggesting cell cycle-dependent functional roles 1. Disease Relevance: TP53TG5 has been investigated in cancer biology contexts, including ovarian cancer models where its expression profile was examined alongside apoptosis-related genes in response to TRAIL and cisplatin treatment 2. Additionally, TP53TG5 has been identified as a candidate gene in intellectual disability pathogenesis through exome sequencing analysis 3. Clinical Significance: The gene's involvement in p53-mediated growth suppression positions it as potentially relevant for understanding tumor biology and p53 function. However, comprehensive characterization of its specific molecular mechanisms and clinical implications remains limited in the available literature.